Skip to main content
. 2010 Jan 11;54(3):1283–1289. doi: 10.1128/AAC.00970-09

FIG. 1.

FIG. 1.

Example of monitoring resistance with the INNO-LiPA HBV DR v2 strip. The patient was receiving lamivudine treatment and developed an M204V resistance mutation and later a compensatory L80V mutation. The patient was switched to adefovir therapy in month 36 and in week 60 developed a new adevofir resistance mutation (N236T).